gr 89696 has been researched along with Allodynia in 2 studies
GR 89696: a potent & selective kappa opioid receptor agonist; RN given refers to (E)-2-butenedioate(1:1); RN for parent cpd not available 11/92; GR 103545 is the (R)-isomer
Excerpt | Relevance | Reference |
---|---|---|
"Antihyperalgesia is defined as the ability to block enhanced sensitivity, usually produced by nerve injury or inflammation, to nociceptive stimuli." | 1.30 | Putative kappa-2 opioid agonists are antihyperalgesic in a rat model of inflammation. ( Caudle, RM; Dubner, R; Ho, J; Mannes, AJ, 1997) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ho, J | 1 |
Mannes, AJ | 1 |
Dubner, R | 1 |
Caudle, RM | 2 |
Eliav, E | 1 |
Herzberg, U | 1 |
2 other studies available for gr 89696 and Allodynia
Article | Year |
---|---|
Putative kappa-2 opioid agonists are antihyperalgesic in a rat model of inflammation.
Topics: Analgesics; Animals; Benzeneacetamides; Benzomorphans; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephal | 1997 |
The kappa opioid agonist GR89,696 blocks hyperalgesia and allodynia in rat models of peripheral neuritis and neuropathy.
Topics: Analgesics, Non-Narcotic; Animals; Cold Temperature; Hot Temperature; Hyperalgesia; Injections, Spin | 1999 |